MMP2, matrix metallopeptidase 2, 4313

N. diseases: 1021; N. variants: 43
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE Tca83 exhibited an E7 to E6 transcript ratio comparable to HeLa (cervix), targeted the ERK1/2 and MMP2 pathways, and was dependent on E6 and E7 to survive and proliferate. 31830929 2019
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE MMP-2 showed the highest value of sensitivity from all examined parameters (in stage I of CC - 93.10%, II - 82.76%, III and IV - 96.88%, total group - 92.05%). 30820752 2019
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE The invasiveness of human cervical cancer associated to the function of Na<sub>V</sub>1.6 channels is mediated by MMP-2 activity. 30158710 2018
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE Therefore, this MMP-2 probe potentially provides a sensitive and specific visual method for cervical cancer screening, diagnosis and prognostic judgment. 28487974 2017
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE Following our previous study design, our clinical data showed that NF‑κB and MMP‑2 levels increased in human CaCx specimens with high Cx32 expression compared to levels in para‑carcinoma of cervical specimens. 28902345 2017
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 GeneticVariation disease BEFREE The leads from the present study suggest the protective role of gene variant -1306C>T at the promoter region of the MMP-2 against HPV-mediated cervical cancer. 26561467 2016
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 GeneticVariation disease BEFREE Our results showed that the MMP2 rs243865 and MMP7 rs11568818 genotypes e were associated with increased susceptibility and development of cervical cancer in Chinese Han population. 26526578 2016
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE Moreover, the chemical inhibition of MMP-2 or MMP-9 significantly reduced the migration of CC Caski or SiHa cells. 26191191 2015
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE The expressions were analysed against different age groups, as to demonstrate whether the expression of MMP-2 and MMP-9 is an early or a late event during the progression of cervical cancer. 24804816 2014
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE Membrane type 1-matrix metalloproteinase (MT1-MMP) participates in the activity of MMP-2, which correlates with cancer of uterine cervix. 22527983 2012
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE This study shows that MZF-1 represses MMP-2 transcription and suggests that this repression may be linked to inhibition of human cervical cancer cell migration and metastasis. 22846578 2012
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix. 21422052 2011
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE Twenty cervical cancer and 20 normal tissues from the same patients were collected to detect MMP-2 mRNA expression. 18177928 2008
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE Matrix metalloproteinases (MMPs) MMP-2, MMP-9, and MT1-MMP are required for basement membrane degradation in cervical carcinoma. 17167534 2006
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE MMP-2, SCCA, and TPS protein expression were significantly higher in patients with CC than in normal controls. 15665394 2004
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression disease BEFREE These suggest that overexpressions of MMP-2 and MT1-MMP, loss of TIMP-2 expression, and up-regulation of beta-catenin by AAC-11 transfection may contribute to the development of cervical cancer invasion. 10780674 2000
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker disease BEFREE Both MMP-2 and TIMP-2 have a key role in extracellular matrix invasion in cervical carcinoma, largely through their elaboration by tumor cells. 10366463 1999